Resources

Selected
  • 烽火通讯股价突破30元可能性分析
Type of publications
Regions
Diseases
446 results found
2021 ∙ Xing, K. Tu, X. Y. Liu, M. Liang, Z. W. Chen, J. N. Li, J. J. Jiang, L. G. Xing, F. Q. Jiang, Y.
Efficacy and safety of COVID-19 vaccines: a systematic review
Adults COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2021 ∙ Sharif, N. Alzahrani, K. J. Ahmed, S. N. Dey, S. K.
Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis
Adults Older adults COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2021 ∙ Campbell, J. Sutherland, J. Bucknall, D. O’hara, L. Heywood, A. Hobbs, M. Ballantyne, A. Gray, L.
Equity in vaccine trials for higher weight people? A rapid review of weight-related inclusion and exclusion criteria for COVID-19 clinical trials
Adults Older adults COVID-19 Coverage Ethical issues
Rating:
Not applicable
2021 ∙ Nyaku, M. Richardson, E. Martinon-Torres, F. Kuter, B. J.
Evaluation of the Safety and Immunogenicity of M-M-RII (Combination Measles-mumps-rubella Vaccine): Clinical Trials of Healthy Children and Adults Published Between 2010 and 2019
Children Adolescents Adults Measles Mumps Rubella Efficacy/effectiveness Safety Administration
Rating:
Critically low
2021 ∙ Biset, G. Woday, A. Mihret, S. Tsihay, M.
Full immunization coverage and associated factors among children age 12-23 months in Ethiopia: systematic review and meta-analysis of observational studies
Africa Ethiopia Newborn Children Parents/caregivers Acceptance Coverage
Rating:
Not applicable
2021 ∙ Kochhar, G. S. Mohan, B. P. Khan, S. R. Chandan, S. Kassab, L. L. Ponnada, S. Desai, A. Caldera, F. Dulai, P. S. Farraye, F. A.
Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysis
Adults Older adults Hepatitis B Efficacy/effectiveness
Rating:
Critically low
2021 ∙ Egunsola, O. Clement, F. Taplin, J. Mastikhina, L. Li, J. W. Lorenzetti, D. L. Dowsett, L. E. Noseworthy, T.
Immunogenicity and Safety of Reduced-Dose Intradermal vs Intramuscular Influenza Vaccines: A Systematic Review and Meta-analysis
Adults Older adults Administration Efficacy/effectiveness Safety
Rating:
Critically low
2021 ∙ Lau, Oscar Vadlamudi, Nirma Khatri
Immunogenicity and Safety of the COVID-19 Vaccines Compared With Control in Healthy Adults: A Qualitative and Systematic Review
Adults Older adults COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2021 ∙ Chen, J. J. Lee, T. H. Tian, Y. C. Lee, C. C. Fan, P. C. Chang, C. H.
Immunogenicity Rates After SARS-CoV-2 Vaccination in People With End-stage Kidney Disease: A Systematic Review and Meta-analysis
Adults Older adults COVID-19 Efficacy/effectiveness Administration
Rating:
Critically low
2021 ∙ Galmiche, Simon Luong Nguyen, Liem Binh Tartour, Eric de Lamballerie, Xavier Wittkop, Linda Loubet, Paul Launay, Odile
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
Loading...